Abstract
The processing of digital medical data (DMD) raises significant legal and ethical challenges. The rapid development of artificial Intelligence (AI) has tremendously influenced the processing of DMD. However, AI may also give rise to concerns about patient privacy breaches and data security risks. China emphasizes the legal and ethical considerations for processing DMD. In this article, we focus upon the parameters of DMD in the context of China’s legal framework and identify related applications of DMD. We explore the legal issues involving processing DMD in China: (1) individual control right/informed consent, (2) institutional obligations, (3) security impact assessment, and (4) secondary use compliance. We also find ethical issues involving processing DMD in China, involving (1) group bias and other data flaws and (2) privacy risks. Building on the above analysis, we propose legal and ethical “toolboxes” for regulating processing DMD in China. In the legal toolbox, there are four tools, including (1) optimizing individual permit and authorization, (2) creating three types of obligations, (3) promoting responsible and explainable security impact assessment, and (4) identifying public interest standards. In the ethical toolbox, there are two tools, including (1) paying particular attention to handling specific groups’ DMD and (2) enhancing accountability of handling DMD.
Keywords
Get full access to this article
View all access options for this article.